REPORT OVERVIEW
- Request a Free sample to learn more about this report
The global oncaspar market size was USD 107.6 million in 2021 and the market is projected to touch USD 231.1 million by 2028, with a growing compound annual growth rate (CAGR) of 11.4% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with intelligent oncaspar experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.
Oncaspar is a medicine or cancer for both children and adults. The medicine is used to treat acute (ALL) lymphoblastic leukaemia. The treatment is used in mixture with other concern medicines to fight against cancer of white blood cells called lymphoblast. Further, it has the active substance pegaspargase. The medicine belongs to a class of drugs called Enzymes, Oncology.
The growing prevalence of blood cancer and high demand for cures are estimated to surge market growth. An increase in obesity across the worldwide and unhealthy lifestyle are responsible for increasing cancer cases. Rising levels of stress and neglect towards regular exercise disturbed human health. These unhealthy lifestyles and increasing number of patients are estimated to fuel market growth. Growing development in healthcare sector to accelerate market growth. Increasing demand for the medicine among professionals and doctors is projected to drive market growth. Side effects associated with the medication such as nausea, weakness, loss of appetite, diarrhea, vomiting, swelling, and redness at injection site. Such side effects are projected to hamper market growth in the forecasted years.
COVID-19 Impact: Growing COVID-19 Cases to Accelerate Market Growth
Increasing number of COVID-19 cases accelerated market growth. Growing awareness among patients to reduce allegoric levels and high adoption of the medicine to fuel market growth. Growth in healthcare sector during pandemic and growing research about COVID-19 vaccines and medicines are projected to drive market progress.
However, lack of manufacturing and disruption in supply and chain demand during pandemic to reduce market growth.
LATEST TRENDS
Growth in Healthcare Sector to Accelerate Market Growth
Increasing adoption of healthcare sector and growing prevalence of cancer diseases are anticipated to accelerate market growth. The medicine is used to treat allergic reactions to other cancer medicine. Evolution of medicines and growing adoption of advanced methods is predicted to accelerate market growth. Growing research and development activities to manufacture effective medicine. High need to reduce the chances of allergies during cancer treatment. Such advantages of the medicine are anticipated to surge oncaspar market growth in the upcoming years.
SEGMENTATION
- Request a Free sample to learn more about this report
- By Type
Based on type, the market is divided into lyophilized oncaspar and liquid oncaspar.
Lyophilized oncaspar is expected to be the leading part of the segmentation type.
- By Application
Based on the application, the market is divided into large hospital and small & medium hospital.
Small & medium hospital is expected to be the leading part of application segmentation.
DRIVING FACTORS
"Benefits of the Medicine to Stimulate Market Growth"
Growing awareness about the benefits of the medicine is estimated to surge market growth. In a study, 75% patients treated with the medicine with the combination of other cancer medicines are free from cancer after seven years. According to another survey, most people suffer from cancer while their treatment adoption of the medicine works more effectively. Growing demand for the medicine among cancer patients and healthcare sector is anticipated to accelerate market growth. Increasing number of cancer patients globally is projected to drive market expansion. This medicine is given by injection into a vein or a muscle by a health care professional. The dosage is based on the body size and response to treatment. Such broad demand for the medicine is estimated to accelerate market growth in the estimated period.
"Improper Lifestyle and Increasing Obesity Cases Globally to Magnify Market Growth"
Increase in cases of obesity the worldwide and unhealthy lifestyles are responsible to increase number of cancer cases. Rising levels of stress and neglect towards regular exercise disturbed human health. These unhealthy lifestyles and an increasing number of cases are estimated to fuel market growth. Growing adoption of lyophilized oncaspar among patients are augmented to foster market growth. Increase disposable income and growing consumer preference for the medicine are anticipated to fuel oncaspar market growth.
RESTRAINING FACTORS
"Side Effects Associated with The Medicine to Hamper Market Growth"
Side effects associated with the medicine such as nausea, weakness, loss of appetite, diarrhea, vomiting, swelling, and redness at injection site. Such side effects are projected to hamper oncaspar market growth in the forecasted years.
REGIONAL INSIGHTS
- Request a Free sample to learn more about this report
"Increase in Number of Obesity Cases in North America to Drive Market Share. "
North America is estimated to account largest oncaspar market share due to increasing number of obesity cases. Growing prevalence of blood cancer and high demand to cure are estimated to surge market growth. Increasing awareness about the benefits of the medicine is projected to surge market growth. Rapid adoption of medicine in the healthcare sector is a predicted to propel market growth.
Europe is anticipated to hold share of the market due to the presence of market players. Growing manufacturing activities in the region are estimated to surge oncaspar market growth.
KEY INDUSTRY PLAYERS
"Leading Players Adopt New Strategies to Stay Competitive"
The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.
List of Market Players Profiled
- Servier (France)
REPORT COVERAGE
This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
| REPORT COVERAGE | DETAILS |
|---|---|
| Market Size Value In | US$ 107.6 Million in 2021 |
| Market Size Value By | US$ 231.1 Million by 2028 |
| Growth Rate | CAGR of 11.4% from 2021 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
| Historical Data Available | Yes |
| Segments Covered | Types & Application |
| Regional Scope | Global |
Frequently Asked Questions
-
What value is the oncaspar market expected to touch by 2028?
The global oncaspar market is expected to reach USD 231.1 million by 2028.
-
What CAGR is the oncaspar market expected to exhibit by 2028?
The oncaspar market is expected to exhibit a CAGR of 11.4% by 2028.
-
Which are the driving factors of the oncaspar market?
Drivers of this oncaspar market are benefits of the medicine and improper lifestyle and increasing obesity cases.
-
Which are the top companies operating in the oncaspar market?
Servier is the top company operating in the oncaspar market.
